United States · FDA National Drug Code directory
Cisplatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-103_24604fc6-875c-4f70-973a-9cca93f9a7a7
- Product NDC
- 63323-103
- Form
- INJECTION, SOLUTION
- Composition / generic term
- CISPLATIN
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20000905
- Source listing expiry
- 20261231
Source-listed ingredients
- CISPLATIN — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (63323-103-51) / 50 mL in 1 VIAL · 63323-103-51
- 1 VIAL in 1 CARTON (63323-103-64) / 200 mL in 1 VIAL · 63323-103-64
- 1 VIAL in 1 CARTON (63323-103-65) / 100 mL in 1 VIAL · 63323-103-65
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →